Location History:
- Stanford, CA (US) (1996)
- Los Altos, CA (US) (1998 - 1999)
- Newton, MA (US) (1999 - 2003)
- Los Altos Hills, CA (US) (1995 - 2004)
- Durham, NC (US) (2009 - 2022)
Company Filing History:
12 out of 5,309 
11 out of 1,373 
11 out of 2,010 
Years Active: 1995-2025
Title: **Victor J. Dzau: A Leader in Cardiovascular Innovations**
Introduction
Victor J. Dzau, based in Durham, NC, is a prominent figure in the field of cardiovascular medicine and cellular reprogramming. With an impressive portfolio of 29 patents, Dzau has significantly contributed to advancing cardiac health through innovative research and groundbreaking methodologies.
Latest Patents
Among his latest patents, Dzau introduced the "Direct reprogramming of cells to cardiac myocyte fate." This method promotes the conversion of cells into cardiomyocytic tissue by interacting with fibrotic tissue, such as scar tissue, utilizing microRNA oligonucleotides. His work facilitates the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyoblasts. Additionally, he disclosed "Compositions and methods for cellular reprogramming," which encompasses innovative compositions that include various microRNAs and an activator of NFκB. This development provides methods for enhancing cardiomyocyte maturation in cells or subjects while also inhibiting this maturation when necessary.
Career Highlights
Dzau has built an impressive career, leveraging his expertise in cardiovascular medicine. He has held significant positions at esteemed institutions such as Leland Stanford Junior University and Brigham and Women's Hospital. His commitment to advancing medical science and patient care places him at the forefront of innovation in his field.
Collaborations
Throughout his career, Dzau has collaborated with notable professionals, including Gary H. Gibbons and Maria Mirotsou. These partnerships have fostered an environment of creativity and ingenuity, essential for pioneering advancements in cardiovascular research.
Conclusion
Victor J. Dzau's contributions to the field of cardiovascular medicine demonstrate a profound commitment to innovation and patient health. His extensive patent portfolio and collaborations with other experts underscore his role as a leader in advancing cardiac therapies. Through continued research and development, Dzau's work is likely to inspire future innovations that will significantly impact cardiovascular health.